Dermatology

Azelaic Acid in Rosacea and Melasma: One Molecule, Two Jobs

Azelaic acid appears in two clinical pictures that share almost nothing: the flushing and papules of rosacea, and the brown patches of melasma. That a single dicarboxylic acid is used for both is not a marketing convenience. It reflects two separate mechanisms, and knowing which one you are relying on changes how you use it, what results to expect, and what you should stop doing alongside it.

A weak acid that does not behave like an exfoliant

Azelaic acid is a nine-carbon dicarboxylic acid. It is poorly soluble in water, which is why nearly every commercial product is a gel, cream or suspension rather than a clear toner, and why the texture often feels slightly chalky on the fingers. Its pKa is high enough that at skin pH only a fraction is uncharged, so penetration is slower and more selective than glycolic or lactic acid.

The practical consequence is that azelaic acid rarely produces the immediate sting and tighten that people associate with acids. Mild transient tingling in the first week or two is common. Burning that lasts past twenty minutes, or redness spreading beyond the area you applied it, is not a sign that it is working harder. It usually means the vehicle is too occlusive for your skin or the concentration is above what you tolerate.

Unlike the exfoliating acids, it does not primarily loosen corneocytes. It is taken up by keratinocytes and affects mitochondrial and inflammatory signalling, and the effects that matter clinically are downstream: less inflammatory output, altered keratinization inside the follicle, and reduced tyrosinase activity in melanocytes. That is why it can be used nightly for months without the thinning people worry about with an AHA routine.

Rosacea: the cathelicidin route

Rosacea is not simply sensitive skin. In the papulopustular subtype, the best-supported model involves an overactive innate immune response in the epidermis. Cathelicidin, an antimicrobial peptide, is produced in excess and cleaved by kallikrein 5 into smaller fragments, including LL-37. Those fragments are both antimicrobial and inflammatory, and they recruit neutrophils while driving vascular reactivity.

Azelaic acid appears to reduce kallikrein 5 activity and to calm the signalling that keeps this loop running. It also has modest activity against Cutibacterium acnes and Demodex, both present at higher density in rosacea skin. Published research suggests the vascular component responds more slowly than the papules, so a reduction in bumps usually precedes any change in background redness by several weeks.

This is also why azelaic acid is a reasonable option for someone who cannot tolerate metronidazole gel vehicles or who wants to avoid repeated topical antibiotics. It is not a substitute for a diagnosis. Steroid-induced rosacea, perioral dermatitis and cutaneous lupus can all look similar at a glance, and each is managed very differently.

Melasma: tyrosinase plus the vessels underneath

In melasma, melanocytes are overactive but not abnormal. They sit above a dermis with increased vascularity, more mast cells and a thickened basement membrane, and the pigment is often a mixture of epidermal and dermal. Azelaic acid inhibits tyrosinase, the rate-limiting enzyme in melanin synthesis, and appears to interfere with the melanocyte signalling that follows ultraviolet and visible light exposure.

Because it acts on enzyme activity rather than destroying pigment already made, visible change depends on epidermal turnover. Pigment sitting in the stratum corneum has to shed. That is measured in weeks to months, and the improvement is gradual and often partial. Dermal pigment is slower still, which is why some patches fade to a point and then plateau for a season.

The vascular component is the part most people miss. If the skin under a melasma patch is chronically irritated or the barrier is compromised, pigment production stays switched on no matter how much tyrosinase inhibitor sits on top of it. Treating the barrier and controlling light exposure are not supportive extras here. They are part of the mechanism.

Concentrations, vehicles and pairing

Cosmetic products typically sit around 10 percent, while prescription formulations go to 15 or 20 percent. Higher concentration does not translate neatly into faster clearance, because tolerability and vehicle design decide how consistently the product gets used. A 10 percent formula applied every night for six months generally outperforms a 20 percent formula used twice a week and abandoned in frustration.

Combined with niacinamide, azelaic acid tends to be well tolerated, and the pair covers both melanin synthesis and pigment transfer. Combined with a retinoid it is workable, but the two should not be introduced in the same month. Some formulas add glycolic acid to improve spreadability, which also raises irritation risk and is worth spotting on the ingredient list if your skin reacts easily.

Where this stops being the right plan

Azelaic acid is often described as pregnancy-safe, and it is one of the few pigment actives clinicians reach for during pregnancy. That does not make self-treatment appropriate for a new or changing pigmented lesion. Melasma is a diagnosis of exclusion, and a patch that is asymmetric, has irregular borders, or itches needs a dermatologist rather than another serum.

If the redness on your cheeks is triggered by heat, spicy food and exercise but comes with no papules, azelaic acid alone will do very little. That pattern is vascular and usually needs a different approach. If you also have dryness, foreign body sensation or recurrent styes, that suggests ocular involvement and needs assessment. None of this is medical advice, and a lesion that has not responded in eight to twelve weeks belongs in a clinic, not in a bigger bottle.